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eratins 8 and 18 (K8/18) are major constituents
of Mallory bodies (MBs), which are hepatocyte cy-
toplasmic inclusions seen in several liver diseases.
K18-null but not K8-null or heterozygous mice form MBs,
which indicates that K8 is important for MB formation.
Early stages in MB genesis include K8/18 hyperphos-
phorylation and overexpression. We used transgenic
mice that overexpress K8, K18, or K8/18 to test the im-
portance of K8 and/or K18 in MB formation. MBs were
induced by feeding 3,5-diethoxycarbonyl-1,4-dihydro-
collidine (DDC). Livers of young K8 or K8/K18 overex-
K
 
pressors had no histological abnormalities despite in-
creased keratin protein and phosphorylation. In aging
mice, only K8-overexpressing livers spontaneously devel-
oped small “pre-MB” aggregates. Only K8-overexpress-
ing young mice are highly susceptible to MB formation
after short-term DDC feeding. Thus, the K8 to K18 ratio,
rather than K8/18 overexpression by itself, plays an es-
sential role in MB formation. K8 overexpression is sufﬁ-
cient to form pre-MB and primes animals to accumulate
MBs upon DDC challenge, which may help explain MB
formation in human liver diseases.
 
Introduction
 
Intermediate filaments (IFs) are a large family of cytoplasmic
and nuclear proteins that are involved in a broad range of dis-
eases that reflect their cell and tissue-specific expression (Herr-
mann et al., 2003; Coulombe and Wong, 2004; Omary et al.,
2004). The nuclear IFs include lamins, whereas examples of
cytoplasmic IFs include desmin and neurofilaments that are
preferentially expressed in muscle and neuronal cells, respec-
tively. In epithelial cells, cytoplasmic IFs consist of types I and
II keratins that are found as obligate noncovalent heteropoly-
mers and are expressed in an epithelial cell–specific manner
(Coulombe and Omary, 2002). Type I and II keratins stabilize
each other via formation of a coil–coil 
 
 
 
 helix and are found in
cells in a 1:1 type I/II stoichiometric ratio. In digestive organ
epithelia, the major IFs are keratin polypeptides 8 and 18 (K8/18),
with variable levels of K7, 19, and 20 depending on the tissue/
cell type (Ku et al., 1999). Adult hepatocytes are unique in that
they express K8/18 exclusively (Omary et al., 2002). The ab-
sence of either K8 or K18 results in the rapid degradation of
most of the remaining keratin partner by ubiquitinylation in or-
der to maintain the 1:1 type I/II keratin protein ratio (Kulesh et
al., 1989; Ku and Omary, 2000).
An important function of K8/18 is to protect hepatocytes
from mechanical and nonmechanical stresses, as demonstrated
using several transgenic animal models (Omary et al., 2002;
Magin et al., 2004; Zatloukal et al., 2004). For example, K8-
null or K18 mutant–expressing mice are highly susceptible to
liver injury, which led to the identification of K8 and K18 vari-
ants in patients with end-stage liver disease (Omary et al.,
2004; Ku et al., 2005). K8/18-related liver disease likely occurs
by a multi-hit process that includes the keratin mutation and
other insults such as viral and toxin-related injuries (Omary et
al., 2002; Ku et al., 2005). K8 and K18 are also the major com-
ponents of Mallory bodies (MBs) and are essential for MB for-
mation (Denk et al., 2000). MBs are typically noted as hyaline,
irregular-shaped cytoplasmic aggregates or deposits found par-
ticularly but not exclusively in hepatocytes of patients with al-
coholic and nonalcoholic steatohepatitis (Denk et al., 2000).
Similar cytoplasmic deposits that contain other IFs are seen
in other diseases, including astrocyte Rosenthal fibers (glial
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fibrillary acidic protein deposits) of Alexander disease and
neurofilament deposits in several neurodegenerative diseases
(Cairns et al., 2004; Omary et al., 2004; Cookson, 2005). These
aggregates are hallmarks of several diseases, but the mecha-
nism of their formation is poorly understood, albeit MBs are
among the most studied as a result of mouse models that include
feeding a diet containing griseofulvin or 3,5-diethoxycarbonyl-
1,4-dihydrocollidine (DDC; Denk et al., 2000).
The accumulation of MBs is a multistep process that in-
cludes liver injury–mediated K8/18 hyperphosphorylation and
K8/18 mRNA and protein overexpression (Yuan et al., 1996;
Cadrin et al., 2000; Denk et al., 2000; Stumptner et al., 2000;
Omary et al., 2002). Keratin induction is asymmetric, particu-
larly at the protein level. For example, K8 protein increases
nearly 5- and then 3-fold, whereas K18 increases nearly 2- and
then 1.5-fold after 1 wk and 2.5 mo of DDC feeding, respec-
tively (Denk et al., 2000). The increases in K8/18 mRNA are
somewhat more prominent (K8, nearly sixfold; K18, nearly five-
fold after 1 wk of DDC feeding; similar levels were seen after
2.5 mo of feeding; Denk et al., 2000) and are likely mediated by
an increase in mRNA stability (Cadrin et al., 2000). Such differ-
ences in keratin induction are physiologically relevant because
the relative K8 versus K18 levels appear to be important for MB
formation. For example, aged K18-null mice (K8 
 
  
 
K18)
spontaneously develop abnormal hepatocytes with K8-positive
MB-like aggregates (Magin et al., 1998). In contrast, K8-null
or heterozygous (
 
 
 
/
 
 
 
) mice (K18 
 
  
 
K8) do not form MBs
even after intoxication with DDC (Zatloukal et al., 2000). How-
ever, differences between in vivo and cell culture models occur
in that transfected K18 is more prone to aggregate than trans-
fected K8 (Nakamichi et al., 2002). Although these studies sug-
gest that keratins are important for MB development, the rela-
tionship between single or dual K8 and K18 overexpression and
MB formation under basal and stimulated conditions remains
unclear. We addressed this issue using transgenic mice that
overexpress human (h) K18 (Abe and Oshima, 1990) or mouse
(m) K8 or mK8/hK18. A previous study described transgenic
mice that overexpressed hK8 and developed progressive chronic
pancreatitis, but, although detailed analysis was not performed,
no liver abnormalities were described (Casanova et al., 1999).
 
Results and discussion
 
Keratin mRNA and protein expression were analyzed in four
transgenic mouse lines: single (K8 or K18) or double overex-
pressors (K8/18) and control wild-type (WT) nonoverexpressors.
Figure 1. Liver histology and keratin mRNA, protein levels, and immune staining in young WT, K8, K18, and K8/18 mice. (A) Real-time PCR of the indicated
keratin mRNA (normalized to ribosomal L7 mRNA) in livers of the four genotypes. For mK8 and mK18 mRNA, the mRNA levels are normalized to those in
WT mice (mean   SD; n   3/genotype). For mice that overexpress hK18, the levels are normalized to hK18 overexpressors (N/A, not applicable; because
WT and K8 mice do not express hK18). (B) Total liver homogenates were prepared, and equal amounts of protein were separated by SDS-PAGE followed
by blotting using Abs to the indicated keratin or phosphokeratin epitopes. Actin is included as a loading control. H, human; m, mouse. (C) Livers from
10-wk-old sex-matched mice were fixed, sectioned, and stained with hematoxylin (H) and eosin (E; a, d, g, and j). Alternatively, liver keratins were visualized
by immunofluorescence staining using Abs to K8/18 (pankeratin; b, e, h, and k) or to K18 pS33 (c, f, i, and l). Arrows (f and l) highlight basal K18 pS33
staining to contrast with the surrounding enhanced staining (asterisks). Insets show separately performed double staining using anti-mK18 (e) and anti-K18
pS33 (f) to highlight some cells (asterisks) with increased K18 and K18 pS33. Bars, 50  m. 
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These lines were generated by mating mK8 overexpressors
(EA5 
 
 
 
/
 
 
 
) together or with hK18 overexpressors (TG2 
 
 
 
/
 
 
 
;
Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200507093/DC1). Analysis of keratin transcription by real-
time PCR demonstrated a 3.2-fold increase of mK8 RNA in the
K8 overexpressors and a similar increase (2.5-fold) in mice that
overexpressed K8/18 as compared with WT mice (Fig. 1 A).
K8 overexpression had a slightly more prominent effect on
K18 mRNA induction (1.8 
 
  
 
0.2) as compared with the ef-
fect of K18 overexpression on K8 (1.3 
 
  
 
0.3). As expected,
hK18 mRNA was detected in the K18 and K8/18 overexpres-
sors (Fig. 1 A). Keratin protein overexpression paralleled the
mRNA changes (Fig. 1 B). For example, mK8 protein in-
creased 
 
 
 
2.5-fold in the K8 and K8/18 overexpressors (see
Protein analysis). K8 overexpression has a more profound
impact on K18 protein induction as compared with K18 over-
expression on K8 protein induction, and K8 
 
  
 
K18 protein lev-
els are highest in the K8/18 double and K8 overexpressors (Fig.
1 B). Therefore, of the K8, 18, or 8/18 lines, the normal 1:1 K8
to K18 liver protein ratio is best approximated in the K8/18
overexpressors while yielding a nearly 2.5-fold increase in
overall keratin protein.
We examined hepatocyte keratin phosphorylation in the
transgenic mouse lines given that keratin dynamics are highly
regulated by phosphorylation and that keratin phosphorylation
serves as a marker of hepatocyte injury and occurs early during
MB formation (Stumptner et al., 2000; Toivola et al., 2004).
Keratin phosphorylation was assessed using phosphospecific
antibodies (Abs) to the well-characterized phosphorylation
sites mK8 phospho- (p)S79 and K18 pS33 (Toivola et al.,
2004). These two sites were selected because changes in their
phosphorylation correlates with liver injury, apoptosis, or mito-
sis depending on the biologic context (Toivola et al., 2004).
There was a limited increase in the specific activity of K8 pS79
in K8 or K18 livers but a more prominent increase in K8/18
livers (Fig. 1 B). The specific activity of K18 pS33 increased
particularly in the K8 transgenic mice as determined by immu-
noblotting (Fig. 1 B, compare K8 with WT vs. K8/18 with
K18) and immunofluorescence staining (Fig. 1 C). Aside from
an increased mosaic staining of the filamentous K8 pS33, there
was no obvious filament reorganization, and sections of livers
from the four genotypes of 10-wk-old mice did not reveal any
MBs or other histologic abnormalities (Fig. 1 C). The mosaic
increase of K8 pS33 staining in some cells correlated with an
increase in K18 staining (Fig. 1 C, e and f; insets). Serum test-
ing of aminotransferases, alkaline phosphatase, total bilirubin,
creatinine, and amylase were normal in all four genotypes (not
depicted). Therefore, keratin overexpression did not induce
MBs in young mice even though K8 and K8/18 mice have ab-
normal increased hepatocyte K8 and K18 phosphorylation.
Because keratin phosphorylation is a hallmark of cell stress
(Omary et al., 1998; Coulombe and Omary, 2002; Toivola et
al., 2004), the increased keratin phosphorylation in the K8
and K8/18 young mice may point to an underlying early stress
response that precedes any obvious liver damage.
Given that MBs form spontaneously in old but not in
young K18-null mice (Magin et al., 1998), we asked whether
keratin deposits form in old mouse livers isolated from WT,
K8, K18, and K8/18 mice. Notably, livers from 2-yr-old K8
mice develop keratin aggregates of varied sizes, whereas livers
of similarly aged WT, K18, or K8/18 mice do not (Fig. 2). The
keratin aggregates consist of small dots located primarily near
the cell periphery and of larger, MB-like cytoplasmic aggre-
gates, which also stained positive for K18 pS33 (Fig. 2, C and D)
even though clear MB formation was not seen by histochemical
staining (not depicted). The larger keratin-containing aggre-
gates uniformly included ubiquitin, whereas the smaller dots
did not (Fig. 2, C and D; insets). Some hepatocytes from K8/18
mice had brighter keratin staining, but keratin aggregates were
Figure 2. Spontaneous pre-MB formation in livers of old K8 mice. Immuno-
fluorescence staining was performed on livers of 2-yr-old WT, K8, K18,
and K8/18 mice. Livers were stained with Abs to K8/18 (pankeratin; A,
C, E, and G) or to K18 pS33 (B, D, F, and H). Arrows (C and D) highlight
keratin aggregates that are seen only in K8-overexpressing mice, whereas
the asterisks highlight fine keratin dots that are likely precursors to the
larger aggregates. Bar, 50  m. Insets show double staining of K8/18 (C)
and ubiquitin (D) and illustrate that the larger keratin aggregates are ubiq-
uitin positive (arrowheads), whereas the smaller keratin dots are ubiquitin
negative (asterisks). 
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rarely found (Fig. 2, G and H). The K8 aggregates excluded
 
 
 
-tubulin and, thus, were not related to centrosomes nor to
apoptosis, as they did not stain with an Ab specific to an apop-
totic K18 fragment, and most did not colocalize with autopha-
gosomes (Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200507093/DC1). Altogether, we hypothesize that the
keratin aggregates noted in the K8-overexpressing old mice rep-
resent pre-MBs as defined by the formation of K8/18-ubiquitin
aggregates that are not easily seen by histochemical staining.
We tested whether the occurrence of pre-MB aggregates
in old K8 mice could render younger K8 mice more susceptible
to MB formation by feeding the four mouse genotypes a DDC-
containing diet. Mice fed with DDC or griseofulvin for 3–4 mo
are established models of MB formation (Yuan et al., 1996;
Cadrin et al., 2000; Denk et al., 2000; Stumptner et al., 2000).
However, in our experimental design, we analyzed the livers at
an early time point of 6 wk after DDC feeding, when MBs are
typically not seen. In DDC-fed mice, there was a significant in-
crease in serum alanine aminotransferase (ALT; an indicator of
hepatocyte necrosis) in K8 as compared with WT, K18, or K8/
18 mice (Fig. 3 A) but no significant difference in liver damage
when assessed by hematoxylin and eosin staining (not de-
picted). Other serologic tests (see Animal feeding and tissue
experiments) were comparable in all four genotypes (not de-
picted). However, MBs were found almost exclusively in the
K8 mice, as confirmed by hematoxylin and eosin staining
(Fig. 3, B and C), standard and immune electron microscopy
(Fig. 3 D), and immunofluorescence staining using antikeratin
and antiubiquitin antibodies (Fig. 4 A). K8 livers had 35 
 
  
 
19
hepatocytes with MBs per 10 high power fields compared with
2.6 
 
 
 
 3.7, 1.5 
 
 
 
 1.7, and 0.2 
 
  
 
0.4 for WT, K18, and K8/18
livers, respectively (Fig. 3 C). Ubiquitin localized in most, if
not all, of the keratin aggregates (Fig. 4 A), whereas p62
(which is a component of MBs; Zatloukal et al., 2000, 2004)
was seen in some of the aggregates (not depicted). After DDC
feeding, keratin protein levels increased dramatically, as ex-
pected in all genotypes (Fig. 4 B), in concert with an increase
in K8 and K18 mRNA levels (not depicted). In addition, phos-
phorylation of K8 S79 and K18 S33 increased similarly in all
four genotypes (not depicted) as described previously for WT
mice (Stumptner et al., 2000). Therefore, K8-overexpressing
mice are highly primed to develop MBs after DDC challenge.
Our study provides direct evidence that perturbations in
individual keratin protein levels, which occur during liver in-
jury, account for MB formation. Overexpression of individual
K8 or K18 or combined K8/18 indicated that an increase in the
ratio of K8 to K18 is a key ingredient for MB formation. Find-
ings in this study and those previously described for K8 
 
 
 
/
 
 
 
or K8 
 
 
 
/
 
 
 
 (which do not form MBs even when challenged)
and K18 
 
 
 
/
 
 
 
 mice (which form MB-like structures spontane-
ously) are summarized in Fig. 5 A. Collectively, these data in-
dicate that the availability of “excess” K8 acts as a nidus for
hepatocyte MB formation and that excess K18 or K8/18 are
well tolerated to the extent that they do not lead to MB forma-
tion. Excess K8 requires additional stimuli that ultimately in-
duce MB formation because K18-null (Magin et al., 1998) and
K8 mice (Fig. 2) develop MBs only at an old age. Additional
Figure 3. ALT levels and MB formation after DDC feeding. WT, K8,
K18, and K8/18 mice (4–5 mice per genotype; 3–4-mo-old sex-matched
mice) were fed a DDC-containing diet for 6 wk followed by harvesting of
the livers and blood. (A) ALT levels (means   SD), with a significant in-
crease noted in K8 as compared with WT mice. (B) Livers from mice de-
scribed in A were fixed and stained with hematoxylin and eosin. Histology
of the livers from WT (a) and K8 (b) mice is shown, but K18 and K8/18
liver histology was very similar to WT (not depicted). Note the significant
MB formation in K8 livers (arrows). Bar, 200  m. (C) MBs were quantified
(see Materials and methods) using the hematoxylin and eosin–stained
liver sections described in B. The P values for comparing the genotypes
WT with K8, K8 with K18, and K8 with K8/18 are shown. Error bars
represent SD. (D) Conventional (a and b) and immune (c–f) electron mi-
croscopy of livers from K8 mice that were fed a DDC-containing diet
show typical-appearing MB deposits. In a, the MB is encircled with a
black line, and in b, arrows highlight IF bundles that are in close proxim-
ity to MBs. For immune electron microscopy, keratins were labeled with
10 nm gold particles (c–e). The particles are difficult to see in c but are
clearly evident in the higher magnification images d and e. As a speci-
ficity control, the grids were also treated with nonimmune serum (f; note
the absence of gold particles as contrasted with e). Arrows in e and f
point to keratin IF bundles. Bars (a), 2  m; (b) 500 nm; (c) 300 nm; (d)
100 nm; (e) 300 nm. N, nucleus. 
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stimuli may include aging and its related oxidative damage
(Holbrook and Ikeyama, 2002) or chronic toxic liver injury,
such as DDC in mice or alcohol or nonalcoholic steatohepatitis
in humans (Fig. 5 B). Keratin overexpression is well tolerated
under basal conditions (Fig. 1) and does not significantly affect
susceptibility to liver injury in DDC-fed mice regardless of
whether MBs form in a prominent (K8 mice) or limited (WT,
K18, or K8/18 mice) fashion (Figs. 3 and 4). Therefore, in
DDC-related injuries, a propensity for MB formation is a re-
flection of preferential K8 overexpression coupled with addi-
tional stimuli, but it does not correlate with the extent of liver
injury per se. Interestingly, the formation of K8-containing ag-
gregates also occurs in a physiological context during early
mouse embryogenesis when K8 and K7 but not type I keratin
proteins are expressed (Lu et al., 2005).
The imbalance in the K8 to K18 ratio may be achieved by
transcriptional or posttranscriptional induction in MB-associated
mouse injury models (Yuan et al., 1996; Cadrin et al., 2000;
Denk et al., 2000; Zatloukal et al., 2000) or by forced expression
(this study). Alternate potential mechanisms include differences
in keratin protein turnover, particularly because proteasome
inhibition occurs as a consequence of protein aggregation
(Bence et al., 2001). In this respect, K8/18 degradation in cul-
tured cells occurs by ubiquitination, and K8 and K18 (but less so)
phosphorylation protects from degradation (Ku and Omary,
2000). Although keratin hyperphosphorylation is an early
event in MB formation (Stumptner et al., 2000), it also corre-
lates with liver injury that is independent of MB formation
(Toivola et al., 2004), but its role in MB genesis is unknown.
Although phospho–site-specific and mouse strain differences
could play an important role in MB formation (Fausther et
al., 2004), the inhibitory effect of K8 hyperphosphorylation
on keratin degradation (Ku and Omary, 2000) may provide a
means to generate a K8 
 
  
 
K18 state after liver injury. In ad-
dition, in vivo proteasome inhibition of rats using the com-
pound PS-341 results in keratin accumulation (Bardag-Gorce
et al., 2004), and mutant ubiquitin B with likely subsequent
interference with MB resorption was found in patient livers
that harbored MBs but not in those without MBs (McPhaul et
al., 2002). Therefore, alterations in K8/18 turnover may also
contribute to a K8 
 
  
 
K18 state. We propose a clinically rele-
vant and testable model whereby MBs form in disease con-
texts that result in K8 
 
  
 
K18 protein induction but not in
situations where there is no induction of K8/18 or where the
induction of K8 
 
≅ 
 
K18 or K18 
 
  
 
K8 (Fig. 5 B). The model
predicts that human diseases that associate with MB forma-
tion, such as alcohol-related liver injury and nonalcoholic
steatohepatitis (Fleming and McGee, 1984; Neuschwander-
Tetri and Caldwell, 2003; Zatloukal et al., 2004), are more
likely to result in a K8 
 
  
 
K18 protein imbalance (K8 
 
 
 
K18). This model may extend to other heteropolymeric IFs,
such as neurofilament-containing inclusions (Cairns et al.,
2004; Strong et al., 2004), although it is not known whether
the stoichiometry of specific neurofilament protein (or inclu-
sion-associated 
 
 
 
 internexin) induction is critical, as is the
case for K8/18.
Figure 4. Immunofluorescence staining of
keratins and ubiquitin and relative K8/18
protein  levels in DDC-fed mouse livers. (A)
Mice were fed a DDC-containing diet for 6 wk
followed by immunofluorescence double stain-
ing of liver sections with anti-K8/18 Ab
(pankeratin; a–d) and antiubiquitin Ab. Arrows
(b and f) highlight the ubiquitin-positive keratin
aggregates. Bar, 50  m. (B) Total protein was
isolated from livers of DDC-fed and control
mice (three separate mice/genotype/treat-
ment) followed by blotting with Abs to the in-
dicated epitopes. Because actin increases
slightly after DDC treatment (not depicted;
Cadrin et al., 2000), heat shock protein 60
(Hsp 60) was used as a loading control. 
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Materials and methods
 
Transgenic mice
 
Transgenic mice that overexpress human WT K18 (called TG2) were pre-
viously described and extensively used (Abe and Oshima, 1990; Ku et
al., 2003; Zhou et al., 2005). For mouse K8 overexpression, a HindDIII
16-kb fragment of the Balb/c mouse K8 gene (EndoA1
 
 
 
; Vasseur et al.,
1985) was injected into zygotes of FVB/n mice. Four independent
founder lines (EA2–EA5) were initially selected, from which the EA5 line
was propagated further. Double K8/18-overexpressing mice were gener-
ated by mating homozygous (
 
 
 
/
 
 
 
) TG2 and EA5 mice. The presence
of transgenes was verified by PCR screening of genomic DNA isolated
from mouse tails using specific primers (Table S1, available at http://
www.jcb.org/cgi/content/full/jcb.200507093/DC1). The primers that
were selected to distinguish between BALB/c and endogenous FVB/n uti-
lize an intronic K8 polymorphism that is found in the FVB/n background.
 
Animal feeding and tissue experiments
 
Mice were killed by CO
 
2
 
 inhalation, and blood was collected by intracar-
diac puncture. Livers were rapidly removed and divided into slices or
pieces that were immediately fixed in 10% formalin (histology), were em-
bedded in optimal cutting temperature (Miles; immunofluorescence staining),
or were snap frozen in liquid N
 
2
 
 (protein/RNA analysis). Fixed tissues were
sectioned and stained using hematoxylin and eosin (Histo-tec Laboratory).
Immunofluorescence staining was performed as described previously (Ku et
al., 2004) using Texas red–conjugated anti–rabbit (Invitrogen) and FITC-
conjugated anti–mouse (Biosource International) secondary Abs. Images
were taken using 100
 
 
 
/NA 1.40 or 60
 
 
 
/NA 1.40 oil lenses (Nikon)
and a microscope (TE300; Nikon) combined with a confocal micro-
scope (MRC1024ES; Bio-Rad Laboratories) and the Lasersharp software
(Carl Zeiss MicroImaging, Inc.). Images were compiled using Adobe Illus-
trator or Adobe Photoshop software. Conventional and immune electron
microscopy were performed as described previously (Toivola et al.,
2000), and samples were viewed and photographed using an electron
microscope (CM-12; Philips). Serologic tests included aspartate aminotrans-
ferase and ALT, alkaline phosphatase, total bilirubin, creatinine, and amy-
lase. For MB induction, sex-matched mice (3–4-mo old; three males and
two females for each genotype) were fed a powdered Formulab  Diet
5008 (Deans Animal Feeds) containing 0.1% DDC (Sigma-Aldrich) for 6 wk
(instead of the typical 3-mo feeding; Zatloukal et al., 2000). The diet was
replenished every 2 d. Statistical analysis for ALT was performed using
Dunnett’s method and for MB quantification using the 
 
t
 
 test. For MB
quantification, 10 randomly selected high power fields were used per
genotype, and the number of hepatocytes with MBs were counted and
presented as means 
 
  
 
SD.
 
Protein analysis
 
Total protein tissue lysates were prepared by homogenization in 2% SDS-
containing sample buffer and analyzed by SDS-PAGE followed by trans-
fer to membranes for immunoblotting and visualization by enhanced
chemiluminescence. The Abs used included (Ku et al., 2004) the following:
rabbit Ab 8592 (anti-m/hK8/K18) and Ab 8250 (anti-K18 pS33); rat
Troma I (anti-mK8) and Troma II (anti-mK18); mouse Ab L2A1 (anti-hK18)
and Ab LJ4 (anti-mK8 pS79); mouse antiactin and anti-hsp60 (NeoMarkers);
mouse anti–
 
 
 
-tubulin (Sigma-Aldrich); mouse Ab M30 (anti-K18 apoptotic
fragment; Roche); anti–microtubule-associated protein light chain 3 (a gift
from R. Kopito, Stanford University, Palo Alto, CA); and mouse anti-p62
and antiubiquitin (Santa Cruz Biotechnology, Inc.). Keratin protein induc-
tion was quantified by densitometric scanning of blots containing serial
dilutions of whole liver homogenates from the transgenic lines (analyzed
on the same gel).
 
Real-time RT-PCR
 
Total RNA was isolated using an RNeasy Midi Kit (QIAGEN). The RNA
was translated into cDNA using oligo-dT primers and Superscript II reverse
transcriptase (Invitrogen). Quantitative real-time PCR was performed with
a Sequence Detection System (ABI Prism 7900; PE Biosystems) and spe-
cific primers (Table S1). Samples were analyzed in quadruplicates, and at
least three individual mice were tested for each genotype. L7 ribosomal
protein was used as an internal control, and keratin and actin cDNA lev-
els were normalized so that L7 expression was near equal in all tested
mice. After confirming that the amplification efficiency was similar for all
genes, transcript levels relative to L7 were determined and reported as
means 
 
 
 
 SD.
 
Online supplemental material
 
Fig. S1 shows breeding and screening of WT, K8, K18, and K8/18 lines.
Fig. S2 shows characterization of keratin aggregates in aging K8 mice.
Table S1 shows sequences of PCR primers used for K8 and K18 transgene
screening and sequences of primers used for real-time PCR.
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Figure 5. Summary of MB formation in different mouse genotypes, and
a model of MB formation depending on K8 versus K18 protein levels.
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